Cargando…
β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy
INTRODUCTION: Tumor-initiating cells (TICs) are rare, stem-like, and highly malignant. Although intravenous hepatitis B and C immunoglobulins have been used for HBV and HCV neutralization in patients, their tumor-inhibitory effects have not yet been examined. Hepatitis B immunoglobulin (HBIG) therap...
Autores principales: | Nakagawa, Chad, Kadlera Nagaraj, Manjunatha, Hernandez, Juan Carlos, Uthay Kumar, Dinesh Babu, Shukla, Vivek, Machida, Risa, Schüttrumpf, Jörg, Sher, Linda, Farci, Patrizia, Mishra, Lopa, Tahara, Stanley M., Ou, Jing-Hsiung James, Machida, Keigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516572/ https://www.ncbi.nlm.nih.gov/pubmed/37744383 http://dx.doi.org/10.3389/fimmu.2023.1204907 |
Ejemplares similares
-
LIN28 and histone H3K4 methylase induce TLR4 to generate tumor-initiating stem-like cells
por: Hernandez, Juan Carlos, et al.
Publicado: (2023) -
Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells
por: Machida, Keigo, et al.
Publicado: (2022) -
c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity
por: Serna, Raphael, et al.
Publicado: (2022) -
Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor‐Initiating Stem‐Like Cells
por: Chen, Chia‐Lin, et al.
Publicado: (2023) -
TLRs, Alcohol, HCV, and Tumorigenesis
por: Machida, Keigo
Publicado: (2010)